Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q8NHV1
UPID:
GIMA7_HUMAN
Alternative names:
Immunity-associated nucleotide 7 protein
Alternative UPACC:
Q8NHV1
Background:
GTPase IMAP family member 7, also known as Immunity-associated nucleotide 7 protein, exhibits GTPase activity through dimer formation. The active site of this enzyme is unique, comprising residues from both subunits, highlighting its intricate mechanism of action.
Therapeutic significance:
Understanding the role of GTPase IMAP family member 7 could open doors to potential therapeutic strategies. Its GTPase activity suggests a pivotal role in cellular processes, making it a target of interest for drug discovery efforts.